Hydroquinone with Vitamin D

Cream

4%  |  8%

Ready to prescribe?
Disclaimer: Images are for reference only; actual products may vary.

Product Overview Coming Soon

Product Overview

Hydroquinone with Vitamin D is a depigmentation or skin-lightening formulation used to manage melasma, chloasma, solar lentigines, freckles, and post-inflammatory hyperpigmentation.

Hydroquinone3,4

Hydroquinone is a phenolic organic compound with the molecular formula C₆H₆O₂. It has applications in both the photography and cosmetic industries. There is substantial evidence supporting its use as a skin-lightening agent. Hydroquinone is typically compounded at concentrations ranging from 2% to 12%. Its efficacy and safety depend on the final concentration, the formulation vehicle, and the chemical stability of the product. Skin-lightening effects may become noticeable within approximately two months of use.

Vitamin D5-8

Vitamin D is a fat-soluble vitamin first discovered in the early 1920s. It exists in two primary forms: D2 (ergocalciferol) and D3 (cholecalciferol). Vitamin D is essential for supporting bone health, enhancing immune function, and regulating calcium and phosphorus levels. In the body, vitamin D is inactive and must be activated to exert its physiological effects. It can be obtained through sun exposure, dietary sources, or supplements. When applied topically, vitamin D has been shown to be absorbed through the skin, producing systemic levels.

References

  1. Cassiano DP, Espósito ACC, da Silva CN, Lima PB, Dias JAF, Hassun K, Miot LDB, Miot HA, Bagatin E. Update on Melasma-Part II: Treatment. Dermatol Ther (Heidelb). 2022 Sep;12(9):1989-2012.
  2. Philipp-Dormston WG. Melasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy. Clin Cosmet Investig Dermatol. 2024 May 22;17:1203-121
  3. Fabian IM, Sinnathamby ES, Flanagan CJ, Lindberg A, Tynes B, Kelkar RA, Varrassi G, Ahmadzadeh S, Shekoohi S, Kaye AD. Topical Hydroquinone for Hyperpigmentation: A Narrative Review. Cureus. 2023 Nov 15;15(11):e48840.
  4. Schwartz C, Jan A, Zito PM. Hydroquinone. https://www.ncbi.nlm.nih.gov/books/NBK539693/ August 22, 2023. Accessed July 22, 2025
  5. Deluca HF. History of the discovery of vitamin D and its active metabolites. Bonekey Rep. 2014 Jan 8;3:479.
  6. Chauhan K, Shahrokhi M, Huecker MR. Vitamin D. Statpearls. April 9, 2023. Accessed July 26, 2025
  7. Clinical Pharmacology vitamin D clinical monograph 2025 https://www.clinicalkey.com/pharmacology/
  8. Sadat-Ali M, Bubshait DA, Al-Turki HA, Al-Dakheel DA, Al-Olayani WS. Topical delivery of vitamin D3: a randomized controlled pilot study. Int J Biomed Sci. 2014 Mar;10(1):21-4.

Hydroquinone1-4

Hydroquinone affects the melanogenesis process by inhibiting tyrosinase. It also inhibits DNA and RNA synthesis and suppresses the formation of melanosomes. The ability of hydroquinone to affect the melanocyte metabolic process may lead to a decrease in the production of melanin.

Vitamin D5-8

Vitamin D (D2 or D3) is absorbed in the gastrointestinal tract and bound to lipoproteins and stored in fat tissue or muscle. It is activated by going through two hydroxylations. The first hydroxylation changes inert vitamin D to 25-hydroxyvitamin D (calcidiol) and the second hydroxylation changes it to the physiologically active form, 1,25 dihydroxyvitamin D (calcitriol). It is hydroxylated in the liver to form 25-hydroxylated derivatives. It is further hydroxylated to 1,25 cholecalciferol or ergocalciferol (activated form calcitriol) in the kidney. Normal 25-hydroxyvitamin D is generally between 40 and 60 ng/mL.  Calcitriol facilitates the reabsorption of calcium from the kidney and reabsorption of calcium and phosphorus from the gastrointestinal tract. It helps to mobilize calcium from the bone. Calcitriol binds to the vitamin D receptor in the nucleus inside the cell. Through this binding to the vitamin D receptor gene transcription is modified with activation of specific genes and suppression of others.

Common3-10

  • Burning sensation, irritation, erythema

Serious10

  • Exogenous ochronosis with prolonged hydroquinone use

Contraindications3-9 

  • Hypersensitivity or intolerance to hydroquinone or vitamin D
  • Presence of active dermatitis, eczema, or open wounds at the application site

Precautions3-9 

  • Use with other agents that can dry or irritate the skin (retinoids, benzoyl peroxide)

Store at 20–25°C (68–77°F) in a cool, dry place, protected from light and moisture. Keep container tightly closed.

  1. Cassiano DP, Espósito ACC, da Silva CN, Lima PB, Dias JAF, Hassun K, Miot LDB, Miot HA, Bagatin E. Update on Melasma-Part II: Treatment. Dermatol Ther (Heidelb). 2022 Sep;12(9):1989-2012.
  2. Philipp-Dormston WG. Melasma: A Step-by-Step Approach Towards a Multimodal Combination Therapy. Clin Cosmet Investig Dermatol. 2024 May 22;17:1203-121
  3. Fabian IM, Sinnathamby ES, Flanagan CJ, Lindberg A, Tynes B, Kelkar RA, Varrassi G, Ahmadzadeh S, Shekoohi S, Kaye AD. Topical Hydroquinone for Hyperpigmentation: A Narrative Review. Cureus. 2023 Nov 15;15(11):e48840.
  4. Schwartz C, Jan A, Zito PM. Hydroquinone. https://www.ncbi.nlm.nih.gov/books/NBK539693/ August 22, 2023. Accessed July 22, 2025
  5. Deluca HF. History of the discovery of vitamin D and its active metabolites. Bonekey Rep. 2014 Jan 8;3:479.
  6. Chauhan K, Shahrokhi M, Huecker MR. Vitamin D. Statpearls. April 9, 2023. Accessed July 26, 2025
  7. Clinical Pharmacology vitamin D clinical monograph 2025 https://www.clinicalkey.com/pharmacology/
  8. Sadat-Ali M, Bubshait DA, Al-Turki HA, Al-Dakheel DA, Al-Olayani WS. Topical delivery of vitamin D3: a randomized controlled pilot study. Int J Biomed Sci. 2014 Mar;10(1):21-4.
  9. PandeyA, Jatana GK, Sonthalia S. Cosmeceuticals. https://www.ncbi.nlm.nih.gov/books/NBK544223/ Accessed July 22, 2025
  10. Bhattar PA, Zawar VP, Godse KV, Patil SP, Nadkarni NJ, Gautam MM. Exogenous Ochronosis. Indian J Dermatol. 2015 Nov-Dec;60(6):537-43.
This information is for educational purposes only.
This compounded product has not been reviewed, approved, or evaluated by the Food and Drug Administration for safety and effectiveness. This product is not intended to diagnose, treat, cure, or prevent any disease. No claims are made regarding treatment, cure, or prevention of any disease or condition.
This information is a summary. It may not cover all possible drug information about this product. For complete product information, refer to the manufacturer’s prescribing information and labeling. Call your doctor for medical advice and/or about side effects. You may report side effects to the FDA at 1-800-FDA-1088. A WP Pharma Labs pharmacist will be happy to answer any questions. For consultation, please call 1-800-441-0048.

EXPLORE MORE

Related Medications

Licensed to ship across the U.S.

Your orders arrive promptly and privately, delivered directly to your door.

Providers: Let’s Partner for Better Patient Care

If you are a physician, clinic, or practice seeking a dependable Compounding Pharmacy partner, WP Pharma Labs is here to help. With dedicated account setup, streamlined ordering and responsive service, we support your therapeutic goals with specialized compounds designed for your patients.

To check product availability, check on the status of an existing order, request refills:
orders@wppharmalabs.com

New providers setup / update an existing account:
newaccounts@wppharmalabs.com